Vol 15, No 3 (2019)
Case report
Published online: 2019-06-26
Advanced solitary fibrous tumour of the pleura — a case report and literature review
Oncol Clin Pract 2019;15(3):185-189.
Abstract
The solitary fibrous tumour (SFT) is a rare tumour, which usually occurs in the pleura. Patients with an advanced SFT have a poor prognosis. The treatment options for recurrent disease are especially limited. We present the case of a 55-year-old female patient with a malignant SFT of the pleura, who received conventional chemotherapy and targeted therapy. This paper focuses on systemic therapy in the treatment of metastatic SFT.
Keywords: solitary fibrous tumourpleurachemotherapy
References
- Chick JF, Chauhan NR, Madan R. Solitary fibrous tumors of the thorax: nomenclature, epidemiology, radiologic and pathologic findings, differential diagnoses, and management. AJR Am J Roentgenol. 2013; 200(3): W238–W248.
- Kalebi AY, Hale MJ, Wong ML, et al. Surgically cured hypoglycemia secondary to pleural solitary fibrous tumour: case report and update review on the Doege-Potter syndrome. J Cardiothorac Surg. 2009; 4: 45.
- Chaigneau L, Kalbacher E, Thiery-Vuillemin A, et al. Efficacy of trabectedin in metastatic solitary fibrous tumor. Rare Tumors. 2011; 3(3): e29.
- Park MS, Ravi V, Conley A, et al. The role of chemotherapy in advanced solitary fibrous tumors: a retrospective analysis. Clin Sarcoma Res. 2013; 3(1): 7.
- Koseła-Paterczyk H, Kozak K, Klimczak A, et al. Skuteczność i bezpieczeństwo stosowania trabektedyny w leczeniu pacjentów, u których rozpoznano zaawansowane tłuszczakomięsaki i mięśniakomięsaki gładkokomórkowe (L-mięsaki). Nowotwory. Journal of Oncology. 2015; 65(6): 451–457.
- Khalifa J, Ouali M, Chaltiel L, et al. Efficacy of trabectedin in malignant solitary fibrous tumors: a retrospective analysis from the French Sarcoma Group. BMC Cancer. 2015; 15: 700.
- Stacchiotti S, Tortoreto M, Baldi GG, et al. Preclinical and clinical evidence of activity of pazopanib in solitary fibrous tumour. Eur J Cancer. 2014; 50(17): 3021–3028.
- van der Graaf WTA, Blay JY, Chawla SP, et al. EORTC Soft Tissue and Bone Sarcoma Group, PALETTE study group. Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet. 2012; 379(9829): 1879–1886.
- Ebata T, Shimoi T, Bun S, et al. Efficacy and safety of pazopanib for recurrent or metastatic solitary fibrous tumor. Oncology. 2018; 94(6): 340–344.
- Levard A, Derbel O, Méeus P, et al. Outcome of patients with advanced solitary fibrous tumors: the Centre Léon Bérard experience. BMC Cancer. 2013; 13: 109.
- Stacchiotti S, Negri T, Palassini E, et al. Sunitinib malate and figitumumab in solitary fibrous tumor: patterns and molecular bases of tumor response. Mol Cancer Ther. 2010; 9(5): 1286–1297.
- Park MS, Patel SR, Ludwig JA, et al. Activity of temozolomide and bevacizumab in the treatment of locally advanced, recurrent, and metastatic hemangiopericytoma and malignant solitary fibrous tumor. Cancer. 2011; 117(21): 4939–4947.
- Boothe JT, Budd GT, Smolkin MB, et al. Durable near-complete response to anti-pd-1 checkpoint immunotherapy in a refractory malignant solitary fibrous tumor of the pleura. Case Rep Oncol. 2017; 10(3): 998–1005.